- Home
- NMRA vs BVS Comparison
NMRA vs BVS Comparison
Compare NMRA & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMRA | BVS |
|---|---|---|
| Founded | 2019 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 554.0M | 617.1M |
| IPO Year | 2023 | 2016 |
Fundamental Metrics
Financial Performance| Metric | NMRA | BVS |
|---|---|---|
| Price | $2.24 | $9.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $7.50 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 1.4M | 448.7K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 5.23 | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | N/A | $7.06 |
| P/E Ratio | ★ N/A | $29.48 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $5.81 |
| 52 Week High | $3.65 | $10.76 |
Technical Indicators
Market Signals| Indicator | NMRA | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 46.79 | 55.15 |
| Support Level | $1.79 | $8.43 |
| Resistance Level | $2.58 | N/A |
| Average True Range (ATR) | 0.17 | 0.38 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 55.00 | 50.24 |
Price Performance
Historical ComparisonAbout NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.